| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $1235.56 | 3% | $1.17T | 53.8 | 129% | 0.5% | Healthcare | 59.9% | 47.4% | ||
| 2 | Johnson & Johnson | $267.24 | 3.1% | $643.31B | 24.2 | -3.8% | 1.9% | Healthcare | 72.1% | 7.9% | ||
| 3 | AbbVie Inc. | $254.65 | -0% | $449.91B | 107.4 | -13.3% | 2.6% | Healthcare | 35.7% | 9.5% | ||
| 4 | Merck & Co., Inc. | $128.86 | 1.6% | $318.26B | 17.7 | -48.3% | 2.5% | Healthcare | 59.3% | 2.5% | ||
| 5 | Novartis AG | $157.03 | 1% | $299.63B | 21.8 | 9.2% | 2.6% | Healthcare | 28.6% | 5.3% | ||
| 6 | AstraZeneca PLC | $193.12 | 1.6% | $299.39B | 29.5 | 33.1% | 1.7% | Healthcare | 35.4% | 9.9% | ||
| 7 | Novo Nordisk A/S | $49.64 | 0.8% | $220.59B | 14.1 | 16.8% | 3.6% | Healthcare | -28.4% | 8.1% | ||
| 8 | Amgen Inc. | $368.10 | 0.5% | $198.66B | 25.9 | 31.1% | 2.6% | Healthcare | 25.7% | 9.1% | ||
| 9 | Gilead Sciences, Inc. | $136.36 | 5.2% | $169.3B | 20.1 | 54.5% | 2.3% | Healthcare | 22% | 3.5% | ||
| 10 | Pfizer Inc. | $24.07 | 1.5% | $136.92B | 17.7 | -5.1% | 7.1% | Healthcare | -4.6% | 1.4% | ||
| 11 | Bristol-Myers Squibb Company | $57.97 | 2.2% | $118.36B | 16.8 | 33.6% | 4.3% | Healthcare | 24.7% | 1.8% | ||
| 12 | GSK plc | $53.32 | 0.4% | $107.23B | 7.2 | 120.3% | 6.1% | Healthcare | 39.6% | 5.4% | ||
| 13 | Sanofi | $42.98 | 0.9% | $103.34B | 11.8 | 96.2% | 5.9% | Healthcare | -11.1% | 14.1% | ||
| 14 | Biogen Inc. | $205.70 | -1.3% | $30.37B | 23.3 | -7.8% | — | Healthcare | 58.1% | 0.4% | ||
| 15 | Grifols, S.A. | $7.21 | 0.6% | $6.1B | 11.1 | 114.9% | 2.9% | Healthcare | -18.7% | 1% | ||
| 16 | Organon & Co. | $13.51 | -0.4% | $3.55B | 18.8 | -67.7% | 2.5% | Healthcare | 39% | -2.1% | ||
| 17 | Bristol-Myers Squibb Company Ce | $0.09 | -8% | $188M | 0.0 | 33.6% | 100% | Healthcare | 266.5% | 1.8% | ||
| 18 | Scilex Holding Company | $9.93 | 23% | $84M | -0.3 | -148.5% | — | Healthcare | 58.9% | -33.2% | ||
| 19 | Citius Oncology, Inc. | $0.71 | 0.2% | $66M | -2.1 | -26.5% | — | Healthcare | -84.9% | — | ||
| 20 | MIRA Pharmaceuticals, Inc. | $0.95 | -0.7% | $40M | -0.7 | -177% | — | Healthcare | -17.6% | — | ||
| 21 | SRX Global Inc. | $1.35 | -25.8% | $7M | -0.0 | -332.5% | — | Healthcare | -96.4% | -158.5% |